Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Financing Activities (2016 - 2025)

Nephros (NEPH) has 16 years of Cash from Financing Activities data on record, last reported at -$2000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the TTM value through Sep 2025 reached -$5000.0, up 28.57%, while the annual FY2024 figure was -$5000.0, 93.67% up from the prior year.
  • Cash from Financing Activities reached -$2000.0 in Q3 2025 per NEPH's latest filing, down from -$1000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $281000.0 in Q1 2022 and bottomed at -$111000.0 in Q4 2022.
  • Average Cash from Financing Activities over 5 years is $10764.7, with a median of -$2000.0 recorded in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 9466.67% in 2022, down 250.0% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at -$37000.0 in 2021, then plummeted by 200.0% to -$111000.0 in 2022, then skyrocketed by 97.3% to -$3000.0 in 2023, then skyrocketed by 66.67% to -$1000.0 in 2024, then crashed by 100.0% to -$2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$2000.0 in Q3 2025, -$1000.0 in Q2 2025, and -$1000.0 in Q1 2025.